Skip to main content

SpyGlass Pharma, Inc.

SGP
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001778922

In the last 90 days, SpyGlass Pharma, Inc. insiders filed 1 open-market purchase and 0 sales; 69 institutions reported holding it in 13F filings for Q3 2026, worth $687.8M in total; no superinvestor holds it.

SEC filings

10-K, 10-Q, 8-K, 20-F and 40-F reports SpyGlass Pharma, Inc. filed with the SEC, newest first.

Livermore lists each filing's form, 8-K items and dates only. To read a filing, open it on SEC.gov; an 8-K's press release or other attachments, such as exhibit 99.1 for Item 2.02, are in the filing index.

SEC filings by SpyGlass Pharma, Inc.
FiledForm8-K itemsPeriodDocumentFiling index
Nov 12, 202610-Q–Sep 30, 2026SECIndex
Nov 12, 20268-K2.028.019.01Nov 11, 2026SECIndex
Oct 19, 20268-K8.019.01Oct 19, 2026SECIndex
Oct 1, 20268-K7.018.019.01Oct 1, 2026SECIndex
Aug 6, 202610-Q–Jun 30, 2026SECIndex
Aug 6, 20268-K2.029.01Aug 6, 2026SECIndex
May 14, 202610-Q–Mar 31, 2026SECIndex
May 14, 20268-K2.029.01May 14, 2026SECIndex
Mar 26, 202610-K–Dec 31, 2025SECIndex
Mar 26, 20268-K2.029.01Mar 26, 2026SECIndex
Mar 9, 20268-K8.019.01Mar 9, 2026SECIndex
Feb 13, 20268-K5.02Feb 12, 2026SECIndex
Feb 9, 20268-K5.025.037.019.01Feb 5, 2026SECIndex